Pharmaceutical

FDA warns of reduced efficacy for oral birth control pill Tydemy

Two lots of Lupin’s Tydemy have been recalled due to a decrease in ascorbic acid levels leading to reduced effectiveness.

Aug 2, 2023 - 20:00
FDA warns of reduced efficacy for oral birth control pill Tydemy
Two lots of Lupin’s Tydemy have been recalled due to a decrease in ascorbic acid levels leading to reduced effectiveness.
Read the original article

Tags:

Previous Article

Atantares raises $13.9m in pre-Series A funding to develop molecular chips

Next Article

Amygdala scores $2m NIAAA grant to develop alcohol use disorder therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sales from controversial drug discount program rose to $54 billion last year

STAT+: Sales from controversial drug discount program r...

Sep 30, 2023

Roche eyes alternate mode of administration for Ocrevus in MS

Roche eyes alternate mode of administration for Ocrevus...

Jul 13, 2023

Pharmacosmos ventures into oncology and merges with G1 Therapeutics

Pharmacosmos ventures into oncology and merges with G1 ...

Aug 9, 2024